Dana-Farber Cancer Institute and 773-bed Brigham and Women's Hospital announced they are developing a genomic database.
Boston facilities team up to create cancer database
The program called Profile scans tumor tissue gathered from adult cancer patients for gene mutations that are linked to cancer, according to a news release. The program has been in development for two years and will be extended to pediatric cancer patients at 27-bed Dana-Farber and 396-bed Children's Hospital Boston next year.
“Profile will put us firmly on the path to realizing the promise of personalized medicine,” Dr. Barrett Rollins, Dana-Farber's chief scientific officer, said in the news release. “We're laying the foundation for the development, testing, and implementation of such therapies, and we expect the project to grow as we discover new cancer-related gene mutations and with the development of new technologies.”
Patients who participate in the program will have their tumor tissue scanned and the scans will be placed in a database with information from their medical record. The hospitals say that linking the data from the scans and the medical record will allow researchers to understand which therapies are most effective against a specific tumor type.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.